Introduction {#section1-1177932217733422}
============

Chagas disease remains a serious health concern in South American countries, with approximately 8 million people in the chronic phase of this parasitosis. *Trypanosoma cruzi*, the causative agent, is mainly transmitted to humans by insects from the Triatominae subfamily distributed throughout the American continent.^[@bibr1-1177932217733422]^

The host-parasite relationship between *T cruzi* and vertebrate hosts has been extensively studied and studies continue to develop new drugs and vaccines.^[@bibr2-1177932217733422],[@bibr3-1177932217733422]^ In contrast, there are still few studies on the host-parasite relationship involving *T cruzi* and its interaction with the microbiota in the triatomine vector gut. Pioneer work by Azambuja et al^[@bibr4-1177932217733422]^ showed that *Serratia marcescens*, belonging to the family Enterobacteriaceae, is a major component of the bacterial microbiota in the digestive tract of triatomines (DTT) that may kill *T cruzi* through mannose-sensitive fimbriae^[@bibr5-1177932217733422],[@bibr6-1177932217733422]^ and could thus affect the epidemiology of Chagas disease. An investigation of the bacterial composition in the DTT was only recently undertaken at a molecular level through 16S ribosomal DNA (rDNA) characterization by da Mota et al^[@bibr7-1177932217733422]^ and Gumiel et al.^[@bibr8-1177932217733422]^ These 2 investigations found that the bacterial microbiota diversity is low (less than 10 major species) and varies in composition depending on the species of host triatomine. Apart from the intracellular endosymbiont genera, *Arsenophonus, Wolbachia*, and *Candidatus Rohrkolberia*, the major bacterial species found in the DTT were from *Serratia* genera and from the suborder Corynebacterineae (*Mycobacterium, Rhodococcus, Gordonia, Corynebacterium*, and *Dietzia*). Another microbiota with a low level of diversity has been described in female mosquitoes (*Anopheles gambiae* and *Aedes aegypti*), which are also hematophagous insects.^[@bibr9-1177932217733422]^

This low number of major bacterial species found in the DTT provides an opportunity to investigate their molecular determinants. Aside from the major bacterial species mentioned above, da Mota et al^[@bibr7-1177932217733422]^ and Gumiel et al^[@bibr8-1177932217733422]^ also found several bacterial species that previously have not been reported to reproduce significantly in DTT. These species belong to the following genera: *Acinetobacter, Actinomyces, Adhaeribacter, Bradyrhizobium, Chryseobacterium, Comamonas, Diaphorobacter, Enterococcus, Erwinia, Geobacillus, Haemophilus, Hydrogenophilus, Janthinobacterium, Marinomonas, Microvirga, Pectobacterium, Propionibacterium, Providencia, Pseudomonas, Shinella, Sphingomonas, Staphylococcus, Stenotrophomonas, Streptococcus, Streptophyta, Williamsia*, and *Xanthobacter*. If some bacterial species reproduce optimally in the DTT, there must be a biochemical basis and it needs elucidation due to the possibility of controlling Chagas disease through paratransgenesis to reduce vector competence with genetically modified symbionts.^[@bibr10-1177932217733422],[@bibr11-1177932217733422]^

The aim of this investigation was to identify enzymatic determinants resulting in the success of bacterial genera in the DTT, such as *Serratia* and the members of Corynebacterineae, in contrast to minor genera, including *Staphylococcus, Streptococcus, Haemophilus*, or *Enterococcus*. Thus, the biochemical differences were analyzed between the GC-rich (rich in guanine + cytosine) and GC-poor bacterial species found in the DTT, emphasizing specific enzymatic functions that could explain the success of the former compared with the latter bacteria.^[@bibr12-1177932217733422][@bibr13-1177932217733422][@bibr14-1177932217733422][@bibr15-1177932217733422]--[@bibr16-1177932217733422]^

Materials and Methods {#section2-1177932217733422}
=====================

The successive methodological steps followed to analyze the genome properties and enzymatic determinants in the particular niche of DTT were as follows:

1.  To set up a metagenomic model of wild microbiota in DTT from species of bacteria having their genome completely sequenced and being as close as possible (from the same genera) to those identified by 16S rDNA sequencing;

2.  To characterize the gross genomic features (genome size, gene number, GC level, enzymatic annotation) from bacteria of the metagenomic model;

3.  To set up a working hypothesis based on the metagenomic model to justify the enzymatic determinants that make certain bacteria outcompete others in the DTT niche;

4.  To validate the inference drawn from the metagenomic model through a bench experiment using a quantitative marker. The bench experiment was a shotgun sequencing characterization of the bacterial population from DTTs after Luria-Bertani broth (LB) culture, whereas the quantitative marker was the ratio of the enzyme annotations that are overrepresented in GC-rich compared with GC-poor bacterial species relative to the DNA-encoded protein samples from these bacteria.

Ethics statement {#section3-1177932217733422}
----------------

The animals used for blood feeding the triatomines at FIOCRUZ were treated according to the Ethical Principles in Animal Experimentation approved by the Ethics Committee in Animal Experimentation (CEUA/FIOCRUZ) under the license numbers LW-24/2013 and following the protocol from *Conselho Nacional de Experimentação Animal/Ministério de Ciência e Tecnologia*. Triatomines were captured under the license L14323-7 given by the *Sistema de Autorização e Informação em Biodiversidade* (SISBIO) of the *Instituto Chico Mendes de Conservação da Biodiversidade/Ministério do Meio Ambiente* (MMA).

Triatomine colonies, gut dissection, and bacterial cultures {#section4-1177932217733422}
-----------------------------------------------------------

*Triatoma infestans, Triatoma vitticeps, Panstrongylus megistus* and *Rhodnius neglectus* are of epidemiologic importance.^[@bibr17-1177932217733422]^ *Dipetalogaster maximus* has no epidemiologic importance, but presents good susceptibility to *T cruzi*, is used in xenodiagnosis, and is limited to Southern California and Mexico where it lives in a rocky habitat in association with lizards.^[@bibr18-1177932217733422]^ The male and female triatomines used were in the fifth instar and maintained on chicken blood over approximately 20 generations in the *Laboratório de Doenças Parasitárias* (*Instituto Oswaldo Cruz---*IOC, *Fundação Oswaldo Cruz---*FIOCRUZ. Triatomines were dissected 7 to 10 days after feeding by opening the dorsal side from the posterior end of the abdomen to the last thoracic segment. Meticulous dissection of the midgut (stomach and intestine) and hindgut (rectum) was performed using a sterile ultrafine insulin syringe needle. Feces were obtained by abdominal compression or spontaneous ejections immediately after feeding. Guts and feces were collected together in sterile Eppendorf tubes and maintained at −20°C until use. All steps were performed under aseptic conditions.

Three guts and their feces of each *T infestans, T vitticeps, D maximus, P megistus*, and *R neglectus* were then incubated in 2-mL Eppendorf tubes filled with liquid LB (Sigma-Aldrich Brasil Ltda., Sao Paulo, Brazil) at 30°C without agitation for circa 48 hours until turbidity, due to bacterial growth, became evident.

DNA extraction from bacterial cultures {#section5-1177932217733422}
--------------------------------------

After incubation in LB medium for 48 hours at 30°C without agitation in 2-mL Eppendorf tubes, the triatomine digestive tracts were removed, and the DNA from the remaining bacterial suspensions was extracted with the Fast DNA Spin Kit for Soil (BIO 101 Systems; Qbiogene, Carlsbad, CA, USA) according to the manufacturer's protocol. DNA concentrations were determined using a NanoDrop spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA). About 1 µg DNA for each sample of the 5 triatomine species was then amplified with a Nextera DNA Library Preparation Kit (Illumina, San Diego, CA, USA) and sequenced through 454 Titanium technology.

Microbial composition of triatomine digestive tract, sequence databases, and GC content {#section6-1177932217733422}
---------------------------------------------------------------------------------------

The predominant bacterial genera identified by denaturing gradient gel electrophoresis (DGGE) in the digestive tract of *T infestans, T vitticeps, D maximus, P megistus*, and *R neglectus* were *Serratia, Erwinia, Candidatus Rohrkolberia, Providencia, Pectobacterium*, and *Arsenophonus*.^[@bibr7-1177932217733422]^ Of these 5 triatomine species, the genus *Triatoma* had a more diverse microbiota.

A previous more detailed study of the microbiota composition from digestive tracts of *Triatoma brasiliensis* collected in the field^[@bibr8-1177932217733422]^ showed that the most abundant bacterial genera found by 454 sequencing of 16S rDNA were *Gordonia* sp. (36%), *Serratia* sp. (18%), *Mycobacterium* sp. (18%), *Corynebacterium* (6%), and *Rhodococcus* sp. (6%). *Serratia* was the most widely distributed genus among the triatomine species investigated here ([Table 1](#table1-1177932217733422){ref-type="table"}). Complete genomes were sequenced for at least one species in most of the bacterial genera identified in this work ([Table 1](#table1-1177932217733422){ref-type="table"}) and can be downloaded from ftp://ftp.ncbi.nih.gov/genomes/genbank/bacteria/. The coding sequences (CDS) were retrieved from the sequences of these genomes, available in \*.fna files (see [Table 1](#table1-1177932217733422){ref-type="table"}), by homologous comparison (tBLASTn) with their protein sequences, available in \*.faa files ("\*" stands for the name of the bacterial species under consideration). The average GC content was then calculated for (1) whole CDS or for (2) the first (GC1), second (GC2), and third (GC3) codon positions of each genome set, using a Perl script. When a complete genome sequence was not available for a given bacterial genus, as in the case of *Arsenophonus* sp. and *Dietzia* sp., a CDS sample was retrieved from GenBank (release 208---June 15, 2015) using the Infobiogen server (see <http://www.infobiogen.fr>) and the ACNUC/QUERY retrieval system^[@bibr19-1177932217733422]^ with the options *t* = cds. The CDS samples used here for the GCx (*x* = 1, 2, 3, or the average of them) calculations are from bacterial species that, in most cases, were not the same as those diagnosed by da Mota et al^[@bibr7-1177932217733422]^ and Gumiel et al,^[@bibr8-1177932217733422]^ although the GC content obtained from these species was considered representative of the genus to which they belonged. Reference was made to Takahashi et al^[@bibr13-1177932217733422]^ who stated that the construction of phylogenetic trees based on oligonucleotide frequency of bacterial species with similar GC contents led to topologies that were congruent at genus and family levels with those constructed from homologous genes. The bacterial genomes in GC-poor and GC-rich species were divided according to whether their GC3 was lower or higher than 50%.

###### 

Sequence materials for GC and enzymatic characterization.

![](10.1177_1177932217733422-table1)

  Genera                                                                        Freq.   Whole genome sequences                                                        GC
  ----------------------------------------------------------------------------- ------- ----------------------------------------------------------------------------- ------
  *Acinetobacter* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^       2       NA                                                                            
  *Actinomyces* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^         1       NA                                                                            
  *Adhaeribacter* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^       1       NA                                                                            
  *Arsenophonus* ^[b](#table-fn3-1177932217733422){ref-type="table-fn"}^        Endo    GenBank                                                                       Poor
  *Bradyrhizobium* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^      1       Bradyrhizobium_japonicum_USDA_6\_uid158851/NC_017249.fna                      Rich
  *Chryseobacterium* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^    1       NA                                                                            
  *Comamonas* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^           1       Comamonas_testosteroni_CNB_2\_uid62961/NC_013446.fna                          Rich
  *Corynebacterium* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^     2015    Corynebacterium_terpenotabidum_Y\_11_uid210639/NC_021663.fna                  Rich
  *Diaphorobacter* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^      2       NA                                                                            
  *Dietzia* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^             5008    GenBank                                                                       Rich
  *Enterococcus* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^        6       Enterococcus_faecalis_D32_uid171261/NC_018221.fna                             Poor
  *Erwinia* ^[b](#table-fn3-1177932217733422){ref-type="table-fn"}^             Low     Erwinia_amylovora_ATCC_49946_uid46943/NC_013971.fna                           Rich
  *Geobacillus* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^         2       NA                                                                            
  *Gordonia* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^            11825   Gordonia_polyisoprenivorans_VH2_uid86651/NC_016906.fna                        Rich
  *Haemophilus* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^         1       Haemophilus_somnus_2336_uid57979/NC_010519.fna                                Poor
  *Hydrogenophilus* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^     15      NA                                                                            
  *Janthinobacterium* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^   1       NA                                                                            
  *Marinomonas* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^         1       Marinomonas_posidonica_IVIA_Po_181_uid67323/NC_015559.fna                     Poor
  *Microvirga* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^          2       NA                                                                            
  *Mycobacterium* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^       5737    Mycobacterium_marinum_M\_uid59423/NC_010612.fna                               Rich
  *Pectobacterium* ^[b](#table-fn3-1177932217733422){ref-type="table-fn"}^      Low     Pectobacterium_carotovorum_PC1_uid59295/NC_012917.fna                         Rich
  *Propionibacterium* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^   5       Propionibacterium_propionicum_F0230a_uid170533/NC_018142.fna                  Rich
  *Pseudomonas* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^         4       Pseudomonas_aeruginosa_RP73_uid209328/NC_021577.fna                           Rich
  *Rhodococcus* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^         1855    Rhodococcus_opacus_B4_uid13791/NC_012522.fna                                  Rich
  *Serratia* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^            4917    Serratia_marcescens_FGI94_uid185180/NC_020064.fna                             Rich
  *Shinella* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^            2       NA                                                                            
  *Sphingomonas* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^        1       Sphingomonas_wittichii_RW1_uid58691/NC_009511.fna                             Rich
  *Staphylococcus* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^      3       Staphylococcus_saprophyticus_ATCC_15305_uid58411/NC_007350.fna                Poor
  *Stenotrophomonas* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^    1       Stenotrophomonas_maltophilia_D457_uid162199/NC_017671.fna                     Rich
  *Streptococcus* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^       1       Streptococcus_oralis_Uo5_uid65449/NC_015291.fna                               Poor
  *Streptophyta* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^        2       NA                                                                            
  *Williamsia* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^          15      NA                                                                            
  *Wolbachia* ^[b](#table-fn3-1177932217733422){ref-type="table-fn"}^           Endo    Wolbachia_endosymbiont_of_Culex_quinquefasciatus_Pel_uid61645/NC_010981.fna   Poor
  *Xanthobacter* ^[a](#table-fn2-1177932217733422){ref-type="table-fn"}^        1       Xanthobacter_autotrophicus_Py2_uid58453/NC_009720.fna                         Rich

Abbreviation: NA, not available.

Bacterial species detected by Gumiel et al.^[@bibr8-1177932217733422]^

Bacterial species detected by da Mota et al.^[@bibr7-1177932217733422]^

Freq. is for the numbers in [Table 2](#table2-1177932217733422){ref-type="table"} of Gumiel et al^[@bibr8-1177932217733422]^ indicating the maximum absolute number of times a genus was detected over each of 4 samples. Low is for the low but uncharacterized level of detection of a genus by DGGE in da Mota et al.^[@bibr7-1177932217733422]^ Endo is for the high but uncharacterized level of detection of an endosymbiont by DGGE in da Mota et al.^[@bibr7-1177932217733422]^

Enzymatic profiling of bacterial genomes used as references {#section7-1177932217733422}
-----------------------------------------------------------

For this study, the classification Enzyme Commission (EC) numbers from the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB) was used. If different enzymes catalyze the same reaction, then they receive the same EC number. Approximately 5500 enzyme reactions have already been classified according to a 4-digit hierarchy that is used to progressively refine classification descriptions. Briefly, the first digit reports on the type of reaction considered, which is divided into 6 main categories: *Oxidoreductases, transferases, hydrolases, lyases, isomerases*, and *ligases*. The second digit of the EC number describes the type of chemical object the reaction is acting on, whereas the third digit often describes the type of donor or acceptor group. Finally, the fourth digit associates the enzyme with its reaction name (see a complete description at <http://www.chem.qmul.ac.uk/iubmb/enzyme/>).

Protein sequences of files (1) NC_018221.faa (*Enterococcus faecalis*), NC_010519.faa (*Haemophilus somnus*), NC_007350.faa (*Staphylococcus saprophyticus*), NC_015291.faa (*Streptococcus oralis*) and (2) NC_010612.faa (*Mycobacterium marinum*), NC_012522.faa (*Rhodococcus opacus*), NC_016906.faa (*Gordonia polyisoprenivorans*), NC_020064.faa (*Serratia marcescens*), and NC_021663.faa (*Corynebacterium terpenotabidum*) were considered representative of GC-poor and GC-rich bacterial species found in the DTT, respectively.^[@bibr8-1177932217733422]^ By taking only the best hits (*E* value \< 0.0001) into account, the protein sequences (BLASTp) of each of the files outlined above were compared with the enzyme sequences from the database of the Kyoto Encyclopedia of Genes and Genomes (KEGG version from June 2015; <http://www.genome.jp/kegg/>) where the EC numbers are available. A homologous hit was considered significant when its identity rate was at least 60% for at least 33 amino acids. For each file of the homology comparison, the EC numbers (<http://www.enzyme-database.org/class.php>) were grouped according to their first (6 classes), second (67 subclasses), third (264 subclasses), and fourth digits (the whole EC number set of 5549 approved enzymes as available from BRENDA---online release as of June, 30, 2015; <http://www.brenda-enzymes.org/all_enzymes.php>; see the "Results" section). Finally, the relative frequency of EC numbers per functional category were compared between GC-poor and GC-rich genomes of bacterial species considered representative of the bacterial genera diagnosed in DTT.

Shotgun sequencing and analysis of DNA from bacterial cultures of triatomine guts {#section8-1177932217733422}
---------------------------------------------------------------------------------

The shotgun sequencing of bacteria from DTT incubated in LB medium was performed to determine the validity of the model proposed above. At the time of the experiment, a representative amplification by polymerase chain reaction would have needed an amount of DNA that was not compatible with that obtained from direct extraction of triatomine feces. Thus, a culture step was introduced prior to shotgun library construction knowing that it would introduce a bias due to the different growth conditions in LB and DTT.

The 723 543 reads obtained by 454 sequencing were mounted into 16 435 contigs using Velvet^[@bibr20-1177932217733422]^ according to <http://ged.msu.edu/angus/tutorials-2011/short-read-assembly-velvet.html> (*k* = 31, ie, 31mers were looking for overlaps between reads) and further assembled with CAP3^[@bibr21-1177932217733422]^ to finally obtain 14 269 nonredundant sequences ([supplementary file S1](http://journals.sagepub.com/doi/suppl/10.1177/1177932217733422)). We then extracted the 738 297 open reading frames (ORF) from both positive and negative strands of these 14 269 sequences and filtered them out for CDS ORFs (cORFs) larger than 99 bp (base pairs) using the universal feature method (UFM),^[@bibr22-1177932217733422],[@bibr23-1177932217733422]^ ending up with 35 105 cORFs compatible with the purine bias found in the CDSs ([supplementary file S2](http://journals.sagepub.com/doi/suppl/10.1177/1177932217733422)). These sequences were then compared (BLASTx) with a data set composed by the protein sequences of GC-rich bacteria from the whole genomes of *C terpenotabidum* (NC_021663.fna), *G polyisoprenivorans* (NC_016906.fna), *M marinum* (NC_010612.fna), *R opacus* (NC_012522.fna), and *S marcescens* (NC_020064.fna), downloaded from ftp://ftp.ncbi.nih.gov/genomes/Bacteria/ and filtered out the homologies for identity rates ≥60% over ≥33 amino acids. We retrieved the sequence subset corresponding to these homologies with a Perl script and compared (BLASTx) them with the subset of protein sequences from KEGG corresponding to the list of EC numbers that are more frequent in GC-rich bacteria compared with GC-poor forms according to their first 3 digits. Finally, we did the same exercise with the protein sequences from the whole genomes of GC-poor bacteria, ie, *S saprophyticus* (NC_007350.fna), *H somnus* (NC_010519.fna), *E faecalis* (NC_018221.fna), and *S oralis* (NC_015291.fna), and compared the results.

Statistics {#section9-1177932217733422}
----------

Due to the different environmental conditions, differential growth of the GC-poor and GC-rich bacteria in DTT and LB were to be expected. Thus, a marker is needed to verify that the model matches the bench experiment (shotgun sequences). Therefore, as a marker, the ratio (proportion) of (1) enzymatic functions that are overrepresented in GC-rich bacteria compared with GC-poor ones relative to (2) the whole DNA--encoded protein sample for the type of bacteria considered (GC-poor or GC-rich) were chosen. Because the relative ratio of these enzymatic functions is different in GC-rich and GC-poor bacteria, then rejection of the null hypothesis of equality of both proportions (1 for GC-rich and 1 for GC-poor bacteria) in the bench experiment is to be expected if it mirrors the model (where both proportions are different).

There are at least 4 different methods to test the equality of 2 proportions, but 1 based on the *Z* score (<https://onlinecourses.science.psu.edu/stat414/node/268>) is presented here. According to this method, the hypothesis of equality of 2 proportions *H*~0~: *p*~1~ = *p*~2~ can be rejected if a quantity, *Z*, is larger than a theoretical value (1.96) of reference for a probability risk α = 0.05. The quantity *Z* is calculated using formula (1):

$$Z = \frac{\left( {\hat{p}}_{1} - {\hat{p}}_{2} \right)}{\sqrt{\hat{p}\left( {1 - \hat{p}} \right)\left( {\frac{1}{n_{1}} + \frac{1}{n_{2}}} \right)}}$$

where,

$$\hat{p} = \frac{Y_{1} + Y_{2}}{n_{1} + n_{2}}$$

is the proportion of successes in the 2 samples combined (*Y*~1~ and *Y*~2~ are the absolute frequency of success in samples 1 and 2, respectively. The sample sizes of *Y*~1~ and *Y*~2~ are referred to as *n*~1~ and *n*~2~, respectively).

Results {#section10-1177932217733422}
=======

In genera of bacteria isolated from *Triatoma* spp., those with GC-rich genomes surpass in relative number (75%) the genera of bacteria with GC-poor genomes (25%).^[@bibr8-1177932217733422]^ In addition, among the genera described by Gumiel et al,^[@bibr8-1177932217733422]^ the most widely represented include species with GC-rich genomes, whereas the genera only marginally represented include bacterial species with GC-poor genomes ([Table 2](#table2-1177932217733422){ref-type="table"}). Obviously, being GC-rich is not sufficient for a bacterium to outperform others present in the gut of triatomines because 45% of the other minor bacterial species were also GC-rich.^[@bibr8-1177932217733422]^ However, because all outperforming bacteria (6 belonging to 6 genera in 6 different families with 5 from Actinomycetales and 1 from Enterobacteriales) were GC-rich, the possibility of the GC level being a key factor for these bacteria in the DTT cannot be ignored ([Table 2](#table2-1177932217733422){ref-type="table"}).

###### 

GC content of coding sequences associated with bacterial genera in digestive tract of triatomines.

![](10.1177_1177932217733422-table2)

  Phylum           Class              Order               Suborder            Family                 Species                            N      GC class   GC, %   σ~GC~   GC1, %   σ~GC1~   GC2, %   σ~GC2~   GC3, %   σ~GC3~   Fr^[a](#table-fn6-1177932217733422){ref-type="table-fn"}^
  ---------------- ------------------ ------------------- ------------------- ---------------------- ---------------------------------- ------ ---------- ------- ------- -------- -------- -------- -------- -------- -------- -------------------------------------------------------------
  Firmicutes       Bacilli            Bacillales          NA                  Staphylococcaceae      *Staphylococcus saprophyticus*     1844   Poor       33.8    4.6     46.8     5.4      31.7     4.6      22.9     3.8      L^[b](#table-fn7-1177932217733422){ref-type="table-fn"}^
  Proteobacteria   α-Proteobacteria   Rickettsiales       NA                  Anaplasmataceae        *Wolbachia* sp.                    1037   Poor       34.4    4.5     44.3     4.8      32.9     4.3      26.1     4.3      Endo^[c](#table-fn8-1177932217733422){ref-type="table-fn"}^
  Proteobacteria   γ-Proteobacteria   Pasteurellales      NA                  Pasteurellaceae        *Haemophilus somnus*               1601   Poor       37.5    5.1     49.5     5.1      34.9     4.5      28.3     5.7      L
  Firmicutes       Bacilli            Lactobacillales     NA                  Enterococcaceae        *Enterococcus faecalis*            2249   Poor       37.8    4.7     49.4     5.0      34.3     4.7      29.8     4.5      L
  Firmicutes       Bacilli            Lactobacillales     NA                  Streptococcaceae       *Streptococcus oralis*             1451   Poor       41.3    5.9     52.2     5.8      34.0     4.6      37.7     7.2      L
  Proteobacteria   γ-Proteobacteria   Oceanospirillales   NA                  Oceanospirillaceae     *Marinomonas posidonica*           2795   Poor       44.6    4.6     54.0     4.4      37.9     3.9      41.7     5.3      L
  Proteobacteria   γ-Proteobacteria   Enterobacteriales   NA                  Enterobacteriaceae     *Arsenophonus nasoniae*            306    Poor       42.3    6.0     45.2     5.9      39.6     6.0      42.2     6.1      Endo
  Proteobacteria   γ-Proteobacteria   Enterobacteriales   NA                  Enterobacteriaceae     *Pectobacterium carotovorum*       3322   Rich       52.2    6.4     59.0     6.0      40.9     4.7      56.7     8.6      L
  Proteobacteria   γ-Proteobacteria   Enterobacteriales   NA                  Enterobacteriaceae     *Erwinia amylovora*                2478   Rich       53.9    6.7     60.2     6.4      41.7     4.9      59.6     9.0      L
  Actinobacteria   Actinobacteria     Actinomycetales     Corynebacterineae   Dietziaceae            *Dietzia* spp.                     157    Rich       68.0    4.7     69.1     5.3      66.3     4.3      68.6     4.4      H^[d](#table-fn9-1177932217733422){ref-type="table-fn"}^
  Proteobacteria   γ-Proteobacteria   Enterobacteriales   NA                  Enterobacteriaceae     *Serratia marcescens*              3620   Rich       59.4    7.5     63.2     6.6      42.7     5.1      72.5     10.8     H
  Proteobacteria   β-Proteobacteria   Burkholderiales     NA                  Comamonadaceae         *Comamonas testosteroni*           3941   Rich       62.0    6.2     65.2     5.3      45.9     4.9      74.8     8.3      L
  Actinobacteria   Actinobacteria     Actinomycetales     Corynebacterineae   Mycobacteriaceae       *Mycobacterium marinum*            4464   Rich       65.6    5.4     68.0     4.9      50.6     5.5      78.0     5.8      H
  Proteobacteria   α-Proteobacteria   Rhizobiales         NA                  Bradyrhizobiaceae      *Bradyrhizobium japonicum*         7029   Rich       64.0    6.1     65.1     4.9      47.9     4.9      78.9     8.6      L
  Actinobacteria   Actinobacteria     Actinomycetales     Corynebacterineae   Gordoniaceae           *Gordonia polyisoprenivorans*      3870   Rich       67.1    5.4     69.0     5.0      51.1     5.2      81.3     6.0      H
  Actinobacteria   Actinobacteria     Actinomycetales     NA                  Propionibacteriaceae   *Propionibacterium propionicum*    2292   Rich       66.4    6.3     68.4     5.5      49.2     5.4      81.6     8.0      L
  Proteobacteria   γ-Proteobacteria   Xanthomonadales     NA                  Xanthomonadaceae       *Stenotrophomonas maltophilia*     3275   Rich       67.2    5.7     69.8     5.6      48.8     5.4      83.0     6.2      L
  Actinobacteria   Actinobacteria     Actinomycetales     Corynebacterineae   Corynebacteriaceae     *Corynebacterium terpenotabidum*   1861   Rich       67.3    5.4     68.8     5.1      49.7     5.3      83.3     5.7      H
  Actinobacteria   Actinobacteria     Actinomycetales     Corynebacterineae   Nocardiaceae           *Rhodococcus opacus*               5908   Rich       67.9    5.7     69.7     4.9      50.6     5.3      83.5     6.7      H
  Proteobacteria   α-Proteobacteria   Rhizobiales         NA                  Xanthobacteraceae      *Xanthobacter autotrophicus*       3783   Rich       67.6    6.0     69.1     5.6      49.7     5.3      84.0     7.3      L
  Proteobacteria   γ-Proteobacteria   Pseudomonadales     NA                  Pseudomonadaceae       *Pseudomonas aeruginosa*           4627   Rich       66.6    6.4     68.7     5.8      46.8     5.8      84.3     7.5      L
  Proteobacteria   α-Proteobacteria   Sphingomonadales    NA                  Sphingomonadaceae      *Sphingomonas wittichii*           4069   Rich       68.7    5.9     69.3     5.6      50.0     5.2      86.7     6.9      L

Abbreviation: NA, not available.

Fr is for the frequency of bacterial species reported in Gumiel et al.^[@bibr8-1177932217733422]^

L is for low frequency.

Endo is for endosymbiont.

H is for high frequency and is highlighted in gray background.

The shading regions in Table 2 is to improve the contrast between GC-rich (gray) and GC-poor (white) genomes.

On comparing GC3 with genome size and gene number for the species of the genera identified by Gumiel et al^[@bibr8-1177932217733422]^ for which a complete genome sequence was available, a significant positive correlations was found for GC3 vs genome size (*r* = .66, *P* \< .01), GC3 vs gene number (*r* = .61, *P* \< .01), and genome size vs gene number (*r* = .99, *P* \< .01) ([Table 3](#table3-1177932217733422){ref-type="table"}).

###### 

Relationships between GC3, genome size, and gene number in the representative bacterial species with complete genome sequence of bacterial genera found in the intestinal tract of triatomines.

![](10.1177_1177932217733422-table3)

  Species                                                                            GC3    Genome, bp   Gene, nb
  ---------------------------------------------------------------------------------- ------ ------------ ----------
  *Staphylococcus saprophyticus* (NC_007350)                                         22.9   2 516 573    2445
  *Haemophilus somnus* (NC_010519)                                                   28.3   2 263 855    1980
  *Enterococcus faecalis* (NC_018221)                                                29.8   2 987 449    2876
  *Streptococcus oralis* (NC_015291)                                                 37.7   1 958 688    1905
  *Marinomonas posidonica* (NC_015559)                                               41.7   3 899 938    3491
  *Pectobacterium carotovorum* (NC_012917)                                           56.7   4 862 911    4246
  *Erwinia amylovora* (NC_013971)                                                    59.6   3 805 872    3437
  *Serratia marcescens* (NC_020064)                                                  72.5   4 858 215    4361
  *Comamonas testosteroni* (NC_013446)                                               74.8   5 373 642    4802
  *Mycobacterium marinum* (NC_010612)                                                78.0   6 636 826    5423
  *Bradyrhizobium japonicum* (NC_017249)                                             78.9   9 207 382    8826
  *Gordonia polyisoprenivorans* (NC_013441)                                          81.3   5 669 804    4945
  *Propionibacterium propionicum* (NC_018142)                                        81.6   3 449 358    2938
  *Stenotrophomonas maltophilia* (NC_017671)                                         83.0   4 769 154    4101
  *Corynebacterium terpenotabidum* (NC_021663)                                       83.3   2 751 232    2369
  *Rhodococcus opacus* (NC_012522)                                                   83.5   7 913 449    7246
  *Xanthobacter autotrophicus* (NC_009720)                                           84.0   5 308 932    4746
  *Pseudomonas aeruginosa* (NC_021577)                                               84.3   6 342 033    5762
  *Sphingomonas wittichii* (NC_009511)                                               86.7   5 382 259    4850
  Correlations                                                                                           
   *r*~GC3 × GenomSz~^[a](#table-fn11-1177932217733422){ref-type="table-fn"}^        0.66   ---          ---
  * r* ~GC3 × GeneNb~ ^[b](#table-fn12-1177932217733422){ref-type="table-fn"}^       ---    0.61         ---
  * r* ~GenomSz × GeneNb~ ^[c](#table-fn13-1177932217733422){ref-type="table-fn"}^   ---    ---          0.99

Correlation for GC3 vs genome size.

Correlation for GC3 vs gene number.

Correlation for genome size vs gene number.

The shading regions in Table 3 is to improve the contrast between GC-rich (gray) and GC-poor (white) genomes.

If the last correlation may seem trivial in bacteria, the first one is not (the second is a consequence of the first given the third). As a consequence of the positive correlation between GC3 and genome size, GC-rich genomes of DTT bacterial microbiota have a potentially more complex metabolism than that of GC-poor genomes, which seems to be an advantage in this system. A more careful analysis of [Table 3](#table3-1177932217733422){ref-type="table"} shows that *Corynebacterium* has a small genome (at least in the species considered here), but this fact is not necessarily a contradiction because several other Corynebacterineae in DTT have large genomes. It simply suggests that *Corynebacterium* (at least the species considered here) may be in a process of genome reduction on the basis of the enzymatic apparatus of the family.

When comparing enzymatic activities in GC-poor and GC-rich bacteria through the evaluation of their relative frequency according to the first digit of the EC numbers ([Table 4](#table4-1177932217733422){ref-type="table"}), *oxidoreductases* might explain the success of GC-rich bacteria because they were 2 times more frequent, on average, than in GC-poor ones.

###### 

Relative frequency (%) of enzymatic functions in GC-poor and GC-rich bacterial species found in triatomine digestive tract according to the first EC number digit.

![](10.1177_1177932217733422-table4)

  ECNO.       Ss     Hs     Ef     So     Average   SD    Sm     Mm     Gp     Ct     Ro     Average   SD    Av~GCr~/Av~GCp~^[a](#table-fn15-1177932217733422){ref-type="table-fn"}^   Class of enzyme function
  ----------- ------ ------ ------ ------ --------- ----- ------ ------ ------ ------ ------ --------- ----- ------------------------------------------------------------------------- --------------------------
  1\. -.-.-   17.9   14.4   12.7   12.8   14.4      2.4   21.2   31.6   30.5   20.3   34.2   27.5      6.4   1.9                                                                       Oxidoreductases
  2\. -.-.-   31.9   33.8   31.6   33.7   32.8      1.2   29.5   28.8   27.6   32.4   25.3   28.7      2.6   0.9                                                                       Transferases
  3\. -.-.-   29.3   27.2   35.5   33.9   31.5      3.9   28.3   21.2   19.6   25.3   19.8   22.8      3.8   0.7                                                                       Hydrolases
  4\. -.-.-   8.2    10.0   6.9    7.2    8.1       1.4   10.1   8.5    9.6    9.3    8.9    9.3       0.6   1.1                                                                       Lyases
  5\. -.-.-   5.3    7.5    6.7    5.1    6.1       1.1   6.2    3.3    4.5    4.3    4.3    4.5       1.0   0.7                                                                       Isomerases
  6\. -.-.-   7.5    7.1    6.6    7.3    7.1       0.4   4.7    6.6    8.3    8.4    7.6    7.1       1.5   1.0                                                                       Ligases

Abbreviations: Ct, *Corynebacterium terpenotabidum*; EC no., Enzyme Commission number; Ef, *Enterococcus faecalis*; Gp, *Gordonia polyisoprenivorans*; Hs, *Haemophilus somnus*; Mm, *Mycobacterium marinum*; Ro, *Rhodococcus opacus*; Sm, *Stenotrophomonas maltophilia*; So, *Streptococcus oralis*; Ss, *Staphylococcus saprophyticus*.

Factor difference where Av~GCr~ is for average of GC-rich and Av~GCp~ is for average of GC-poor.

The shading regions in Table 4 is to improve the contrast between GC-rich (gray) and GC-poor (white) genomes.

According to this observation, the enzymatic comparison of the second digit ([Table 5](#table5-1177932217733422){ref-type="table"}) revealed a larger number of subcategories (6, ie, *acting on the CH-CH group of donors*---EC:1.3.-.-, *acting on the CH-NH~2~ group of donors*---EC:1.4.-.-, *acting on single donors with incorporation of molecular oxygen*---EC:1.13.-.-, *acting on paired donors with incorporation or reduction of molecular oxygen*---EC:1.14.-.-, *acting on iron-sulfur proteins as donors*---EC:1.18.-.-) with a larger EC number frequency (≥2 times more frequent) in GC-rich compared with GC-poor bacteria in *oxidoreductases* than in the other 4 categories of the first digit level, ie, 2 (*acting on ether bonds*---EC:3.3.-.-, *acting on carbon-carbon bonds*---EC:3.7.-.-) in *hydrolases*, 1 (*intramolecular lyases*---EC:5.5.-.-) in *isomerases*, and 1 (*forming carbon-sulfur bonds*---EC:6.2.-.-) in *ligases*. The largest differences of EC relative frequency, according to the second digit within those of the first digit category, between GC-poor and GC-rich bacteria were due to *acting on single donors with incorporation of molecular oxygen*---EC:1.13.-.- (difference of \~24 times) and *acting on paired donors with incorporation or reduction of molecular oxygen*---EC:1.14.-.- (difference of \~8 times). The differences due to *acting on iron-sulfur proteins as donors*---EC:1.18.-.- (difference of \~5 times), *acting on ether bonds*---EC:3.3.-.- (difference of \~6 times), *acting on carbon-carbon bonds*---EC:3.7.-.- (difference of \~4 times), and *forming carbon-sulfur bonds*---EC:6.2.-.- (difference of \~4 times) were also relatively large (the other differences being around 2 times). Thus, the functional variability of the enzymatic apparatus seems to be important for a bacterium to be able to outperform the others in the intestinal environment of triatomines. In addition, we found that even if the function *acting on diphenols and related substances as donors* (EC:1.10.-.-) exists only at a low rate in all GC-rich bacteria of [Table 5](#table5-1177932217733422){ref-type="table"}, it is simply absent from the GC-poor bacteria found in DTT. This kind of function is an example of a larger metabolic complexity in GC-rich bacteria in the DTT environment.

###### 

Relative frequency (%) of enzymatic functions in GC-poor and GC-rich bacterial species found in triatomine digestive tract according to the 2 first EC number digits.

![](10.1177_1177932217733422-table5)

  ECNO.      Ss    Hs    Ef    So    Average   SD    Sm    Mm    Gp    Ct    Ro    Average   SD    Av~GCr~/Av~GCp~^[a](#table-fn18-1177932217733422){ref-type="table-fn"}^   Class of enzyme function
  ---------- ----- ----- ----- ----- --------- ----- ----- ----- ----- ----- ----- --------- ----- ------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------
  1.3.-.-    1.3   1.4   1.2   1.3   1.3       0.1   1.6   5.1   4.6   2.8   5.2   3.8       1.6   2.9                                                                       Acting on the CH-CH group of donors
  1.4.-.-    0.9   0.2   0.3   0.3   0.4       0.3   0.9   0.9   0.9   1.3   1.6   1.1       0.3   2.7                                                                       Acting on the CH-NH2 group of donors (amino acid oxidoreductase)
  1.10.-.-   0.0   0.0   0.0   0.0   0.0       0.0   0.4   0.1   0.2   0.3   0.1   0.2       0.1   ∞                                                                         Acting on diphenols and related substances as donors (diphenol oxidoreductases)
  1.13.-.-   0.0   0.1   0.0   0.0   0.0       0.1   0.6   0.6   0.8   0.1   1.5   0.7       0.5   24.5                                                                      Acting on single donors with incorporation of molecular oxygen (monooxygenases)
  1.14.-.-   0.8   0.6   0.1   0.1   0.4       0.4   1.4   4.3   4.9   2.1   3.8   3.3       1.5   8.2                                                                       Acting on paired donors, with incorporation or reduction of molecular oxygen (dioxygenases)
  1.18.-.-   0.1   0.0   0.2   0.0   0.1       0.1   0.3   0.2   0.4   0.4   0.5   0.4       0.1   5.0                                                                       Acting on iron-sulfur proteins as donors
  3.3.-.-    0.1   0.0   0.1   0.0   0.0       0.1   0.1   0.4   0.2   0.3   0.4   0.3       0.1   6.1                                                                       Acting on ether bonds
  3.7.-.-    0.1   0.0   0.0   0.0   0.0       0.1   0.1   0.1   0.2   0.0   0.2   0.1       0.1   4.4                                                                       Acting on carbon-carbon bonds
  5.5.-.-    0.0   0.1   0.0   0.1   0.1       0.1   0.2   0.1   0.2   0.1   0.1   0.1       0.0   2.2                                                                       Intramolecular lyases
  6.2.-.-    0.6   0.5   0.5   0.1   0.4       0.2   0.5   2.3   1.7   0.6   3.3   1.7       1.2   4.0                                                                       Forming carbon-sulfur bonds

Abbreviations: Ct, *Corynebacterium terpenotabidum*; EC no., Enzyme Commission number; Ef, *Enterococcus faecalis*; Gp, *Gordonia polyisoprenivorans*; Hs, *Haemophilus somnus*; Mm, *Mycobacterium marinum*; Ro, *Rhodococcus opacus*; Sm, *Stenotrophomonas maltophilia*; So, *Streptococcus oralis*; Ss, *Staphylococcus saprophyticus*.

Factor difference where Av~GCr~ is for average of GC-rich and Av~GCp~ is for average of GC-poor.

The shading regions in Table 5 is to improve the contrast between GC-rich (gray) and GC-poor (white) genomes and is expected to improve table readability.

The comparison of the third digit place of EC numbers ([Table 6](#table6-1177932217733422){ref-type="table"}) for difference of enzymatic activity between GC-poor and GC-rich bacteria of the DTT showed a consistently larger number of enzymes involved in oxygen and nitrogen processing suggesting a much larger ability to cope with the degradation of complex substrates of higher chemical stability such as those containing aromatic rings (aryls). These enzymes can be mainly grouped under EC numbers 1.13.11.-, 1.4.3.-, 1.3.99.-, and 1.14.99.- but also to a lesser extent in 1.13.12.-, 1.14.11.-, 1.14.12.-, 1.14.13.-, 1.1.99.-, and 1.7.99.-.

###### 

Relative frequency (%) of enzymatic functions in GC-poor and GC-rich bacterial species found in the triatomine digestive tract according to the 3 first EC number digits.

![](10.1177_1177932217733422-table6)

  ECNO.       Ss    Hs    Ef    So    Average   SD    Sm    Mm    Gp    Ct    Ro    Average   SD    Av~GCr~/Av~GCp~^[a](#table-fn21-1177932217733422){ref-type="table-fn"}^   Class of enzyme function
  ----------- ----- ----- ----- ----- --------- ----- ----- ----- ----- ----- ----- --------- ----- ------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------
  1.1.2.-     0.0   0.0   0.0   0.0   0.0       0.0   0.1   0.2   0.1   0.1   0.0   0.1       0.1   ∞                                                                         With a cytochrome as acceptor
  1.1.3.-     0.0   0.0   0.1   0.1   0.1       0.1   0.0   0.2   0.3   0.0   0.4   0.2       0.2   2.8                                                                       With oxygen as acceptor
  1.1.99.-    0.1   0.0   0.1   0.0   0.1       0.1   0.5   0.1   0.3   0.1   0.2   0.2       0.2   4.8                                                                       With unknown physiological acceptors
  1.2.1.-     1.5   0.9   0.9   0.3   0.9       0.5   1.5   2.1   2.6   1.8   3.5   2.3       0.8   2.6                                                                       With NAD+ or NADP+ as acceptor
  1.3.99.-    0.3   0.6   0.2   0.1   0.3       0.2   0.6   4.5   3.4   1.8   4.7   3.0       1.8   9.6                                                                       With unknown physiological acceptors
  1.4.1.-     0.6   0.1   0.3   0.1   0.3       0.2   0.5   0.3   0.5   0.7   0.9   0.6       0.2   2.0                                                                       With NAD+ or NADP+ as acceptor
  1.4.3.-     0.0   0.1   0.0   0.0   0.0       0.1   0.3   0.5   0.4   0.3   0.6   0.4       0.1   14.2                                                                      With oxygen as acceptor
  1.4.4.-     0.2   0.0   0.0   0.0   0.1       0.1   0.1   0.2   0.0   0.3   0.1   0.1       0.1   2.8                                                                       With a disulfide as acceptor
  1.5.3.-     0.0   0.0   0.0   0.0   0.0       0.0   0.2   0.1   0.5   0.1   0.2   0.2       0.2   ∞                                                                         With oxygen as acceptor
  1.6.1.-     0.0   0.2   0.0   0.0   0.1       0.1   0.2   0.3   0.3   0.1   0.1   0.2       0.1   3.5                                                                       With NAD+ or NADP+ as acceptor
  1.7.99.-    0.0   0.1   0.0   0.0   0.0       0.1   0.7   0.1   0.0   0.0   0.3   0.2       0.3   6.7                                                                       With unknown physiological acceptors
  1.9.3.-     0.0   0.0   0.1   0.0   0.0       0.0   0.0   0.1   0.2   0.3   0.1   0.1       0.1   5.3                                                                       With oxygen as acceptor
  1.13.11.-   0.0   0.1   0.0   0.0   0.0       0.1   0.5   0.4   0.6   0.0   1.2   0.5       0.4   17.5                                                                      With incorporation of 2 atoms of oxygen
  1.13.12.-   0.0   0.0   0.0   0.0   0.0       0.0   0.1   0.3   0.3   0.1   0.5   0.2       0.2   ∞                                                                         With incorporation of 1 atom of oxygen (internal monooxygenases or internal mixed function oxidases)
  1.14.11.-   0.0   0.0   0.0   0.1   0.0       0.1   0.2   0.1   0.3   0.0   0.2   0.1       0.1   4.3                                                                       With 2-oxoglutarate as 1 donor, and incorporation of 1 atom each of oxygen into both donors
  1.14.12.-   0.2   0.0   0.0   0.0   0.1       0.1   0.2   0.0   0.2   0.4   0.4   0.2       0.2   4.5                                                                       With NADH or NADPH as 1 donor, and incorporation of 2 atoms of oxygen into 1 donor
  1.14.13.-   0.5   0.5   0.1   0.0   0.3       0.3   0.6   1.0   3.0   0.6   1.7   1.4       1.0   4.9                                                                       With NAD or NADH as 1 donor, and incorporation of 1 atom of oxygen
  1.14.99.-   0.1   0.0   0.0   0.0   0.0       0.1   0.0   0.1   0.3   0.3   0.4   0.2       0.2   9.2                                                                       Miscellaneous
  1.17.7.-    0.0   0.1   0.0   0.0   0.0       0.1   0.1   0.1   0.1   0.0   0.0   0.1       0.0   2.1                                                                       With an iron-sulfur protein as acceptor
  1.18.1.-    0.1   0.0   0.2   0.0   0.1       0.1   0.2   0.2   0.4   0.4   0.6   0.4       0.2   5.1                                                                       With NAD+ or NADP+ as acceptor
  2.7.11.-    0.4   0.0   0.2   0.3   0.2       0.2   0.2   0.8   1.1   0.6   1.3   0.8       0.4   3.6                                                                       Protein-serine/threonine kinases
  2.8.3.-     0.1   0.2   0.0   0.0   0.1       0.1   0.2   0.7   0.5   0.6   1.4   0.7       0.4   7.7                                                                       CoA-transferases
  2.10.1.-    0.0   0.1   0.0   0.0   0.0       0.1   0.1   0.1   0.1   0.0   0.0   0.1       0.0   2.1                                                                       Molybdenumtransferases or tungstentransferases with sulfide groups as acceptors
  3.1.6.-     0.0   0.2   0.0   0.1   0.1       0.1   0.2   0.3   0.1   0.1   0.4   0.2       0.1   2.4                                                                       Sulfuric ester hydrolases
  3.3.2.-     0.1   0.0   0.1   0.0   0.1       0.1   0.1   0.4   0.2   0.1   0.4   0.3       0.2   5.1                                                                       Ether hydrolases
  4.3.3.-     0.0   0.0   0.1   0.0   0.0       0.0   0.3   0.0   0.0   0.1   0.0   0.1       0.1   4.1                                                                       Amine-lyases
  5.1.99.-    0.0   0.0   0.0   0.0   0.0       0.0   0.1   0.1   0.3   0.1   0.3   0.2       0.1   ∞                                                                         Acting on other compounds
  5.3.3.-     0.1   0.0   0.1   0.1   0.1       0.1   0.3   0.4   0.3   0.1   0.2   0.3       0.1   3.2                                                                       Transposing C=C bonds
  5.5.1.-     0.0   0.1   0.0   0.1   0.1       0.1   0.2   0.1   0.2   0.1   0.1   0.2       0.0   2.4                                                                       Miscellaneous
  6.2.1.-     0.6   0.5   0.5   0.1   0.4       0.2   0.6   2.6   1.9   0.6   3.6   1.9       1.3   4.3                                                                       Miscellaneous

Abbreviations: Ct, *Corynebacterium terpenotabidum*; EC no., Enzyme Commission number; Ef, *Enterococcus faecalis*; Gp, *Gordonia polyisoprenivorans*; Hs, *Haemophilus somnus*; Mm, *Mycobacterium marinum*; Ro, *Rhodococcus opacus*; Sm, *Stenotrophomonas maltophilia*; So, *Streptococcus oralis*; Ss, *Staphylococcus saprophyticus*.

Factor difference where Av~GCr~ is for average of GC-rich and Av~GCp~ is for average of GC-poor.

The shading regions in Table 6 is to improve the contrast between GC-rich (gray) and GC-poor (white) genomes.

With the list of EC numbers (n = 30) that are overrepresented in GC-rich bacteria according to the first 3 digits ([Table 6](#table6-1177932217733422){ref-type="table"}), the protein sequences were retrieved corresponding to the EC numbers fully described on the 4 digits (n = 778) in (1) *S saprophyticus* (n = 39), *H somnus* (n = 25), *E faecalis* (n = 29), and *S oralis* (n = 11), ie, 26 EC numbers on average (σ = 11.6) for GC-poor bacteria and (2) *C terpenotabidum* (n = 55), *G polyisoprenivorans* (n = 96), *M marinum* (n = 73), *R opacus* (n = 116), and *S marcescens* (n = 95), ie, 87 EC numbers on average (σ = 23.0) for GC-rich bacteria. This statistic means that GC-rich bacteria have enzymes with 3.3 times more enzymatic functionalities than GC-poor ones, on average, according to the list of [Table 6](#table6-1177932217733422){ref-type="table"}, which sustains the hypothesis that GC-rich bacteria outperform GC-poor bacteria because of their more complex metabolism, which seems to be an advantage in the DTT. Most enzymatic activities were found in *dehydrogenases* (aldehyde and amino acid), *oxygenases* (mono and di), and *ligase* (*acetate-CoA*), which are enzymatic activities involved in the very first steps of molecular degradation and synthesis.

[Table 7](#table7-1177932217733422){ref-type="table"} shows that among 35 enzymatic reactions that are overrepresented in GC-rich bacteria, the large majority are from *oxidoreductases* (74%) followed by *transferases* and *ligases* (9% each) with *hydrolases* and *lyases* in last position accounting for only 6% and 3%, respectively. A closer look at [Table 7](#table7-1177932217733422){ref-type="table"} enables understanding that the enzyme groups, which most explain the differences between GC-rich and GC-poor bacteria, are ranked by decreasing level of factor difference (Av~GCr~/Av~GCp~) and that the data of [Table 7](#table7-1177932217733422){ref-type="table"} can be reorganized as shown in [Table 8](#table8-1177932217733422){ref-type="table"}.

###### 

Relative frequency (%) of enzymatic functions in GC-poor and GC-rich bacterial species found in the triatomine digestive tract according to the 4 EC number digits.

![](10.1177_1177932217733422-table7)

  ECNO.        Ss    Hs    Ef    So    Average   SD    Sm     Mm     Gp     Ct    Ro     Average   SD     Av~GCr~/Av~GCp~^[a](#table-fn24-1177932217733422){ref-type="table-fn"}^   Class of enzyme function
  ------------ ----- ----- ----- ----- --------- ----- ------ ------ ------ ----- ------ --------- ------ ------------------------------------------------------------------------- --------------------------------------------------------------------
  1.1.99.1     1.0   0.0   0.0   0.0   0.3       0.5   2.0    1.0    1.0    1.0   2.0    1.4       0.5    5.6                                                                       Choline dehydrogenase
  1.2.1.2      4.0   1.0   1.0   0.0   1.5       1.7   7.0    8.0    7.0    2.0   9.0    6.6       2.7    4.4                                                                       Formate dehydrogenase
  1.2.1.3      3.0   0.0   1.0   0.0   1.0       1.4   3.0    4.0    5.0    2.0   14.0   5.6       4.8    5.6                                                                       Aldehyde dehydrogenase (NAD+)
  1.2.1.7      1.0   1.0   0.0   0.0   0.5       0.6   1.0    3.0    2.0    2.0   1.0    1.8       0.8    3.6                                                                       Benzaldehyde dehydrogenase (NADP+)
  1.2.1.8      1.0   0.0   0.0   0.0   0.3       0.5   5.0    0.0    1.0    1.0   2.0    1.8       1.9    7.2                                                                       Betaine-aldehyde dehydrogenase
  1.2.1.10     0.0   0.0   3.0   0.0   0.8       1.5   1.0    1.0    1.0    0.0   5.0    1.6       1.9    2.1                                                                       Acetaldehyde dehydrogenase (acetylating)
  1.2.1.16     1.0   1.0   0.0   0.0   0.5       0.6   1.0    1.0    2.0    1.0   2.0    1.4       0.5    2.8                                                                       Glyceraldehyde-3-phosphate dehydrogenase (NADP+) (phosphorylating)
  1.2.1.27     0.0   1.0   0.0   0.0   0.3       0.5   1.0    1.0    3.0    0.0   5.0    2.0       2.0    8.0                                                                       Methylmalonate-semialdehyde dehydrogenase (acylating)
  1.2.1.38     1.0   0.0   0.0   0.0   0.3       0.5   1.0    0.0    1.0    1.0   1.0    0.8       0.4    3.2                                                                       *N*-acetyl-g-glutamyl-phosphate reductase
  1.2.1.70     1.0   1.0   0.0   0.0   0.5       0.6   1.0    1.0    1.0    1.0   1.0    1.0       0.0    2.0                                                                       Glutamyl-tRNA reductase
  1.3.99.1     2.0   3.0   1.0   0.0   1.5       1.3   8.0    6.0    9.0    2.0   7.0    6.4       2.7    4.3                                                                       Succinate dehydrogenase
  1.4.1.1      3.0   0.0   1.0   0.0   1.0       1.4   3.0    4.0    6.0    4.0   8.0    5.0       2.0    5.0                                                                       Alanine dehydrogenase
  1.4.1.2      2.0   0.0   0.0   0.0   0.5       1.0   2.0    1.0    0.0    0.0   6.0    1.8       2.5    3.6                                                                       Glutamate dehydrogenase
  1.4.1.13     2.0   0.0   1.0   0.0   0.8       1.0   3.0    3.0    5.0    2.0   6.0    3.8       1.6    5.1                                                                       Glutamate synthase (NADPH)
  1.4.3.1      0.0   0.0   0.0   0.0   0.0       0.0   1.0    1.0    1.0    2.0   3.0    1.6       0.9    ∞                                                                         [d]{.smallcaps}-aspartate oxidase
  1.4.4.2      2.0   0.0   0.0   0.0   0.5       1.0   2.0    3.0    0.0    2.0   3.0    2.0       1.2    4.0                                                                       Glycine dehydrogenase (decarboxylating)
  1.5.3.1      0.0   0.0   0.0   0.0   0.0       0.0   4.0    1.0    5.0    1.0   5.0    3.2       2.0    ∞                                                                         Sarcosine oxidase
  1.6.1.2      0.0   2.0   0.0   0.0   0.5       1.0   2.0    2.0    3.0    1.0   3.0    2.2       0.8    4.4                                                                       NAD(P)+ transhydrogenase (Re/Si-specific)
  1.7.99.4     0.0   1.0   0.0   0.0   0.3       0.5   12.0   1.0    0.0    0.0   6.0    3.8       5.2    15.2                                                                      Nitrate reductase
  1.13.11.2    0.0   1.0   0.0   0.0   0.3       0.5   3.0    4.0    2.0    0.0   11.0   4.0       4.2    16.0                                                                      Catechol 2,3-dioxygenase
  1.13.11.24   0.0   1.0   0.0   0.0   0.3       0.5   2.0    2.0    0.0    0.0   3.0    1.4       1.3    5.6                                                                       Quercetin 2,3-dioxygenase
  1.14.12.1    2.0   0.0   0.0   0.0   0.5       1.0   3.0    0.0    1.0    1.0   3.0    1.6       1.3    3.2                                                                       Anthranilate 1,2-dioxygenase (deaminating, decarboxylating)
  1.14.13.1    1.0   0.0   0.0   0.0   0.3       0.5   5.0    1.0    4.0    1.0   6.0    3.4       2.3    13.6                                                                      Salicylate 1-monooxygenase
  1.14.13.8    0.0   0.0   0.0   0.0   0.0       0.0   1.0    1.0    4.0    1.0   3.0    2.0       1.4    ∞                                                                         Dimethyl aniline monooxygenase (N-oxide-forming)
  1.14.99.3    1.0   0.0   0.0   0.0   0.3       0.5   0.0    1.0    2.0    2.0   2.0    1.4       0.9    5.6                                                                       Heme oxygenase (decyclizing)
  1.17.7.1     0.0   1.0   0.0   0.0   0.3       0.5   1.0    2.0    1.0    0.0   1.0    1.0       0.7    4.0                                                                       4-Hydroxy-3-methylbut-2-en-1-yldiphosphate synthase
  1.18.1.2     1.0   0.0   2.0   0.0   0.8       1.0   2.0    1.0    3.0    2.0   5.0    2.6       1.5    3.5                                                                       Ferredoxin---NADP+ reductase
  1.18.1.3     0.0   0.0   0.0   0.0   0.0       0.0   1.0    1.0    1.0    1.0   6.0    2.0       2.2    ∞                                                                         Ferredoxin---NAD+ reductase
  2.7.11.1     1.0   0.0   1.0   2.0   1.0       0.8   2.0    12.0   12.0   4.0   29.0   11.8      10.6   11.8                                                                      Nonspecific serine/threonine protein kinase
  2.8.3.1      0.0   0.0   0.0   0.0   0.0       0.0   1.0    9.0    4.0    1.0   17.0   6.4       6.8    ∞                                                                         Propionate CoA-transferase
  2.10.1.1     0.0   1.0   0.0   0.0   0.3       0.5   1.0    2.0    1.0    0.0   1.0    1.0       0.7    4.0                                                                       Molybdopterin molybdotransferase
  3.1.6.1      0.0   1.0   0.0   1.0   0.5       0.6   2.0    5.0    0.0    1.0   7.0    3.0       2.9    6.0                                                                       Arylsulfatase
  3.3.2.1      1.0   0.0   1.0   0.0   0.5       0.6   1.0    4.0    1.0    0.0   1.0    1.4       1.5    2.8                                                                       Isochorismatase
  4.3.3.7      0.0   0.0   1.0   0.0   0.3       0.5   5.0    0.0    0.0    1.0   0.0    1.2       2.2    4.8                                                                       4-Hydroxy-tetrahydrodipicolinate synthase
  6.2.1.1      2.0   0.0   0.0   0.0   0.5       1.0   2.0    2.0    6.0    1.0   15.0   5.2       5.8    10.4                                                                      Acetate-CoA ligase
  6.2.1.3      1.0   1.0   1.0   0.0   0.8       0.5   4.0    5.0    6.0    2.0   9.0    5.2       2.6    6.9                                                                       Long-chain-fatty-acid-CoA ligase
  6.2.1.26     0.0   1.0   1.0   0.0   0.5       0.6   1.0    1.0    1.0    0.0   3.0    1.2       1.1    2.4                                                                       *o*-Succinylbenzoate-CoA ligase

Abbreviations: Ct, *Corynebacterium terpenotabidum*; EC no., Enzyme Commission number; Ef, *Enterococcus faecalis*; Gp, *Gordonia polyisoprenivorans*; Hs, *Haemophilus somnus*; Mm, *Mycobacterium marinum*; Ro, *Rhodococcus opacus*; Sm, *Stenotrophomonas maltophilia*; So, *Streptococcus oralis*; Ss, *Staphylococcus saprophyticus*.

Factor difference where Av~GCr~ is for average of GC-rich and Av~GCp~ is for average of GC-poor.

The shading regions in Table 7 is to improve the contrast between GC-rich (gray) and GC-poor (white) genomes.

###### 

Enzyme reactions of [Table 7](#table7-1177932217733422){ref-type="table"} classified by decreasing Av~GCr~/Av~GCp~.

![](10.1177_1177932217733422-table8)

  Av~GCr~/Av~GCp~^[a](#table-fn27-1177932217733422){ref-type="table-fn"}^   S. no.   EC no.       Enzymatic function
  ------------------------------------------------------------------------- -------- ------------ ---------------------------------------------------------
  10 to 16                                                                  1        1.13.11.2    Catechol 2,3-dioxygenase
                                                                            2        1.7.99.4     Nitrate reductase
                                                                            3        1.14.13.1    Salicylate 1-monooxygenase
                                                                            4        2.7.11.1     Nonspecific serine/threonine protein kinase
                                                                            5        6.2.1.1      Acetate---CoA ligase
  5 to \<10                                                                 1        1.2.1.27     Methylmalonate-semialdehyde dehydrogenase
                                                                            2        1.2.1.8      Betaine-aldehyde dehydrogenase
                                                                            3        6.2.1.3      Long-chain-fatty-acid-CoA ligase
                                                                            4        3.1.6.1      Arylsulfatase
                                                                            5        1.1.99.1     Choline dehydrogenase
                                                                            6        1.2.1.3      Aldehyde dehydrogenases
                                                                            7        1.13.11.24   Quercetin 2,3-dioxygenase
                                                                            8        1.14.99.3    Heme oxygenase---biliverdin-producing
                                                                            9        1.4.1.13     Glutamate synthase---NADPH
                                                                            10       1.4.1.1      Alanine dehydrogenase
  4 to \<5                                                                  1        4.3.3.7      4-Hydroxy-tetrahydrodipicolinate synthase
                                                                            2        1.2.1.2      Formate dehydrogenase
                                                                            3        1.6.1.2      NAD(P)+ transhydrogenase---Re/Si-specific
                                                                            4        1.3.99.1     Succinate dehydrogenase
                                                                            5        1.4.4.2      Glycine dehydrogenase---aminomethyl-transferring
                                                                            6        1.17.7.1     Cytidine diphosphate-4-dehydro-6-deoxyglucose reductase
  2 to \<4                                                                  1        2.10.1.1     Molybdopterin molybdotransferase
                                                                            2        1.2.1.7      Benzaldehyde dehydrogenase
                                                                            3        1.4.1.2      Glutamate dehydrogenase
                                                                            4        1.18.1.2     Ferredoxin---NADP+ reductase
                                                                            5        1.2.1.38     *N*-acetyl-g-glutamyl-phosphate reductase
                                                                            6        3.3.2.1      Isochorismatase
                                                                            7        6.2.1.26     *o*-Succinylbenzoate---CoA ligase
                                                                            8        1.2.1.10     Acetaldehyde dehydrogenase
                                                                            9        1.2.1.70     Glutamyl-tRNA reductase
  \<2                                                                       1        1.4.3.1      [d]{.smallcaps}-Aspartate oxidase
                                                                            2        1.5.3.1      Sarcosine oxidase
                                                                            3        1.14.13.8    Flavin-containing monooxygenase
                                                                            4        1.18.1.3     Ferredoxin---NAD+ reductase
                                                                            5        2.8.3.1      Propionate CoA-transferase

Abbreviation: EC no., Enzyme Commission number.

Factor difference where Av~GCr~ is for average of GC-rich and Av~GCp~ is for average of GC-poor.

In conclusion, we can say from the divisions in [Table 8](#table8-1177932217733422){ref-type="table"} that *oxygenases* (incorporation of oxygen in organic substrates) and *CoA ligases* (a central function in energy storage) make up the main significant differences, in comparison with the more basic metabolic functions, between the GC-poor and GC-rich bacteria. In addition, this difference emphasizes the existence of a larger metabolic variety of enzymatic systems in GC-rich bacteria than in GC-poor ones in the DTT. Also, the relative frequency of the enzymes ranked Av~GCr~/Av~GCp~ \< 2 is low in GC-rich bacteria, but because they are absent in GC-poor bacteria, they are probably of significance too.

The shotgun sequencing of bacteria from DTT grown in LB medium produced a total number of 723 543 readings whose size followed a bimodal distribution with the significant mode at 350 bp ([Figure 1A](#fig1-1177932217733422){ref-type="fig"}). The average size significantly increased after contig assembling as can be seen in [Figure 1B](#fig1-1177932217733422){ref-type="fig"}; however, most of the ORFs remained below 100 bp ([Figure 1C](#fig1-1177932217733422){ref-type="fig"}). Filtering of cORFs with UFM resulted in a final sample of 35 105 cORFs mostly in the range of 100 to 300 bp ([Figure 1D](#fig1-1177932217733422){ref-type="fig"}), which is in the acceptable limit to perform homology comparison.

![Relative frequency of shotgun sequences associated with bacteria found in the digestive tract of triatomines. (A) Size of reads obtained by 454 Titanium technology, (B) contig size after successive read assembling with Velvet and CAP3, (C) size of ORFs extracted from read contigs, and (D) size of coding ORFs after UFM filtering. cORFs indicate coding open reading frames; ORFs, open reading frames.](10.1177_1177932217733422-fig1){#fig1-1177932217733422}

From the shotgun sequence samples, 2233 significant homologies (best hit) were found among the putative 35 105 cORFs with the representative species of the genera of GC-rich bacteria reported by Gumiel et al.^[@bibr8-1177932217733422]^ Among the 2233 sequences, 425 (19.0%) had significant homologies with KEGG for the EC number list of [Table 6](#table6-1177932217733422){ref-type="table"}. In contrast, 19 715 significant homologies (best hit) were found among the putative 35 105 cORFs with the representative species of the genera of GC-poor bacteria reported by Gumiel et al.^[@bibr8-1177932217733422]^ Among the 19 715 sequences, 1424 (7.2%) had significant homologies with KEGG for the EC number list of [Table 6](#table6-1177932217733422){ref-type="table"}. Because the sample sizes are very different, one must be concerned with a statistical consistency of the factor \~2.7 (close to the theoretical value of 3.3 found with the model) of overrepresented enzymes ([Tables 6](#table6-1177932217733422){ref-type="table"} and [7](#table7-1177932217733422){ref-type="table"}) observed in GC-rich compared with GC-poor bacteria. The *Z* test applied to the comparison of 2 proportions allows the formal conclusion that the null hypothesis of proportion equality must be rejected because *Z*~obs~ (19) \> *Z*~th~ (1.96). Thus, despite a bias introduced by LB fermentation is favorable for the growth of GC-poor bacteria, the conclusion from the shotgun DNA sequencing is that overrepresented enzymatic activities are more frequent, in relative terms, in a medium fermented by GC-rich than in a medium fermented by GC-poor bacteria, as suggested by the model analysis based on complete genome sequences available from National Center for Biotechnology Information (NCBI).

Discussion {#section11-1177932217733422}
==========

A recent investigation compared the microbiota of DTT in the presence or absence of *T cruzi*.^[@bibr24-1177932217733422]^ Globally, it showed a predominance of GC-rich bacterial species (without considering the intracellular endosymbiont *Arsenophonus*)^[@bibr25-1177932217733422]^ as previously described^[@bibr7-1177932217733422],[@bibr8-1177932217733422]^ except for *Staphylococcus* which predominated in some individuals of *P megistus* and *T infestans*. However, the results of Díaz et al^[@bibr24-1177932217733422]^ may be equivocal because the V3-V4 hypervariable region of 16S rDNA produces a less accurate quantitative description than with the V1-V3 region used by Gumiel et al,^[@bibr8-1177932217733422]^ particularly for *Staphylococcus*. Also, with the V3-V4 region, differences between expected and observed frequencies of 10 to 300 times were reported by Zheng et al^[@bibr26-1177932217733422]^ for this latter genus, whereas the measure obtained using V1-V3 region was close to the expected value.

The GC level of a genome is an interesting variable to consider because it is robust in the sense that it is expected to be globally conserved at the level of the family rank.^[@bibr13-1177932217733422]^ Thus, if one GC-poor bacterial species is present in one family, there is a major likelihood that another species of that family will also be GC-poor. The same reasoning also applies to GC-rich organisms. However, in special situations, such as in endosymbiosis where the selective constraints are not those normally encountered by the members of the family, the above tendency is violated because endosymbionts are generally GC-poor, independent of the family they belong to. The GC-poor trait of endosymbionts may be due to an evolutionary convergence induced by the peculiar constraints imposed by the intracellular environment although this is debateable.^[@bibr27-1177932217733422]^ The fact that the luminal environment of DTT in which *T cruzi* thrives is very different compared with that of intestinal epithelial cells was sufficient to eliminate the endosymbionts, *Arsenophonus, Wolbachia, Candidatus*, and *Rohrkolberia* from the present analysis.

Predominant bacterial species are GC-rich,^[@bibr8-1177932217733422]^ which raises the question of whether a cause and effect relationship exists between a bacterial species being GC-rich and its growth success^[@bibr28-1177932217733422],[@bibr29-1177932217733422]^ in the DTT environment. In fact, the positive correlation between GC3 and genome size suggests that, in the DTT, bacterial species with GC-rich genomes have a potentially more complex metabolism than those with GC-poor genomes, which would be an advantage for the bacteria in this niche.

The most significant differences that we found between the bacterial groups were due to *oxidoreductase* enzymes that are much more numerous in GC-rich than GC-poor bacteria and seem to confer a metabolic advantage to GC-rich bacteria in an environment such as blood, in particular, *nitrate reductases* and *oxygenases* that are common in GC-rich bacteria.

In the enzymatic reaction involving *nitrate reductases* (EC 1.7.99.4, KEGG map 910),^[@bibr30-1177932217733422]^ the electron transport system is similar to that of aerobic respiration.^[@bibr31-1177932217733422],[@bibr32-1177932217733422]^ It can be complemented by vitamin K to generate the energy required to survive in anaerobic conditions.^[@bibr33-1177932217733422]^

*Oxygenases* are enzymes that oxidize a substrate by the transference of gaseous oxygen. *Dioxygenases* transfer both oxygen atoms of O~2~ into the substrate,^[@bibr34-1177932217733422]^ whereas *monooxygenases*, such as *phenolases* (*cytochrome P450 oxidases*), incorporate only one atom of molecular oxygen into a substrate, such as phenols, and the other atom is reduced to H~2~O.^[@bibr35-1177932217733422]^ *Oxygenases* are usual in soil bacteria because oxygen reactivity plays important roles in the degradation of complex substrates. In particular, ring-cleaving *dioxygenases* catalyze key reactions in the aerobic microbial degradation of aromatic compounds. Many pathways converge to catecholic intermediates. An example of the degradadation of a complex substrate is *catechol 2,3-dioxygenases* (EC 1.13.11.2) that catalyzes the opening of the benzene ring (KEGG maps 361, 362, 622, 643) and converts catechol into semialdehyde (OHC-R-COOH).^[@bibr36-1177932217733422],[@bibr37-1177932217733422]^ Ring-cleaving *dioxygenases* that are active toward ring compounds belong to the cupin superfamily. Cupin-type *dioxygenases* also involve *quercetinases* (*flavonol 2,4-dioxygenases*), which open up 2 C-C bonds of the heterocyclic ring of quercetin, a widespread plant flavonol.^[@bibr38-1177932217733422]^ In GC-rich bacteria, several other enzymes involved in ring modification or heteroatom oxidation are also available such as (1) *arylsulfatases* (EC 3.1.6.1), (2) *benzaldehyde dehydrogenases---NADP*^+^ (EC 1.2.1.7),^[@bibr39-1177932217733422]^ and (3) *flavin-containing monooxygenases* (EC 1.14.13.8), which can oxidize a wide array of heteroatoms, particularly soft nucleophiles, such as amines, sulfides, and phosphites from xeno-substrates, with no common structural features, to facilitate their excretion.^[@bibr40-1177932217733422],[@bibr41-1177932217733422]^

In the DTT, *oxygenases* have been shown to allow the access to iron of bacteria that encode that enzymatic system via hemoglobin degradation with *heme oxygenases---biliverdin-producing* (EC 1.14.99.3).^[@bibr42-1177932217733422]^ *Heme oxygenase* is an enzyme that catalyzes the degradation of heme and produces biliverdin, iron, and carbon monoxide.^[@bibr43-1177932217733422][@bibr44-1177932217733422]--[@bibr45-1177932217733422]^ Biliverdin is subsequently converted to bilirubin by *biliverdin reductases*. Iron is an essential nutrient required for the survival of most bacteria.^[@bibr46-1177932217733422]^ Bioavailability of iron in many environments such as soil or sea is limited by the very low solubility of the Fe^3+^ ion. Microbes release siderophores to scavenge iron from these mineral phases by formation of soluble Fe^3+^ complexes that can be taken up by active transport mechanisms. Many siderophores are nonribosomal peptides,^[@bibr47-1177932217733422],[@bibr48-1177932217733422]^ although several are biosynthesized independently. Some pathogenic bacteria, such as *S marcescens*, can use heme and hemoproteins as iron sources, independently of siderophore production, by mechanisms involving outer membrane heme-binding proteins and heme transport systems.^[@bibr49-1177932217733422],[@bibr50-1177932217733422]^ The iron-binding protein, transferrin, produces a marked increase in *S marcescens* hemolytic activity.^[@bibr51-1177932217733422]^

The levels of extracellular iron available within a host are limited, with most of the free iron being complexed to high-affinity binding proteins such as transferrin. To circumvent this low iron availability, pathogens have developed sophisticated mechanisms to use the host's iron-containing and heme-containing proteins. The mechanism by which gram-positive bacteria, such as *Corynebacterium diphtheriae*, acquire heme is similar to the heme transport with siderophore^[@bibr52-1177932217733422]^ and involves iron-chelating molecules excreted in the bacterial environment. Once the heme has been transported across the outer membrane and is localized within the cytoplasm, it is degraded by heme oxygenase.^[@bibr53-1177932217733422],[@bibr54-1177932217733422]^

In contrast to *oxygenases, oxidases* (that reduce molecular oxygen to hydrogen peroxide or to water) and *dehydrogenases* (by transferring hydrogen from one substance to another) are mainly, if not exclusively, involved in energy metabolism. Many of the *hydrogenases* predominating in GC-rich bacteria are involved in many different central pathways such as glycolysis, the tricarboxylic acid cycle and oxidative phosphorylation that are essential to cell success in their environment.

As shown by Unrean and Srienc,^[@bibr55-1177932217733422]^ a "cell system has a natural tendency to evolve with time towards an asymptotic state with maximum rate of entropy production." In addition, De Martino et al^[@bibr56-1177932217733422]^ showed that "growth rate can be explained in terms of a trade-off between the higher fitness of fast-growing phenotypes and the higher entropy of slow-growing ones." From the results of this article and those of Unrean and Srienc^[@bibr55-1177932217733422]^ and De Martino et al,^[@bibr56-1177932217733422]^ it can be deduced that the success of GC-rich compared with GC-poor bacteria in the DTT is due to their enhanced ability to metabolize chemically complex substrates. The higher entropy of their metabolic networks may at least result from the predominance of *hydrogenase* functions in central metabolic pathways such as those for amino acid and nucleotide metabolism. In parallel with these increases in enzymatic functions, a conserved set of *CoA* enzymes was also found to be predominant in GC-rich bacteria and involved in different pathways such as the synthesis of chemical bond between large molecules (EC 6.2.1.1),^[@bibr57-1177932217733422]^ toxic compound degradation (EC 2.8.3.1, EC 1.2.1.10),^[@bibr58-1177932217733422]^ and fatty acid (EC 6.2.1.3) and amino acid (EC 4.3.3.7)^[@bibr59-1177932217733422]^ metabolism.

The higher metabolic activity found in GC-rich bacteria suggests that signaling proteins should also be significantly increased. Indeed, a large difference was found for the *nonspecific serine/threonine protein kinases* (EC 2.7.11.1), which belong to the family of transferases, specifically protein-serine/threonine kinases. These enzymes transfer phosphates to the oxygen atom of a serine or threonine side chain in proteins. This process is called phosphorylation and is known to regulate most of the cellular pathways, especially those involved in signal transduction.^[@bibr60-1177932217733422]^

In agreement with De Martino et al,^[@bibr56-1177932217733422]^ the size inversion of GC-rich and GC-poor bacterial population found in the shotgun sequencing analysis is not surprising because the rich LB medium is more favorable for fast-growing bacteria with small genomes and less enzymatic abilities (lower metabolic network entropy). During experiments in this study, to have sufficient DNA, it was necessary to amplify it for sequencing and bacterial culturing were necessary steps, but, of course, at a cost of a bias. The population bias favored GC-poor bacteria and demonstrates the importance of using culture-independent techniques for in situ microbiota investigation. In this respect, the strategy of describing the microbiota composition by 16S rDNA sequencing prior to any further metagenomic description is surely the best, provided that the complete genome sequences for the metagenomes investigated are available. Thus, complete genome sequences allow the construction of a model suitable to determine what can be reasonably expected from the present experiments. Despite its bias, the shotgun analysis undertaken shows that the inferences proposed through the present model are still relevant. Therefore, the species believed to be representative of their respective genera are indeed representative in the context of this work because the proportion of predominant enzymes in the experiments is similar to that of the model.

Shotgun sequencing of microbiota is expensive, and the large amount of data provided can be difficult to analyze, especially when a eukaryote vector and blood meal source are involved as most of the sequences come from the host gut and not from the rare microbiota it contains.^[@bibr61-1177932217733422]^ For instance, the genome of *Rhodnius prolixus* RproC1 was predicted to be about 733 Mb, whereas the average size of each bacterial genome sequence of its digestive tract is only about 4 to 5 Mb.^[@bibr62-1177932217733422]^ Another limitation of shotgun sequencing is that the information it provides on the composition of a microbiota depends on a reference set of microbial genomes which is still only small, typically in the range of few thousand genomes.^[@bibr63-1177932217733422]^ In contrast, large numbers of 16S rDNA gene sequences are available for comparative analyses. For example, the RDP Release 11.5 of September 30, 2016 consisted of 3 356 809 aligned and annotated 16S rDNA sequences (<http://rdp.cme.msu.edu/>).

The 1550 bp of the 16S gene consist of 8 highly conserved regions (U1-U8) and 9 variable regions across the bacterial domain.^[@bibr64-1177932217733422]^ Identifying the organisms populating a microbial community and their relative abundances is the typical primary objective of investigations based on 16S rDNA amplicon characterization. A similarity comparison of 16S gene sequences is usually used as the *gold standard* for taxonomic identification at least at the genus level.^[@bibr65-1177932217733422]^ The characterization of 16S amplicons by DGGE has been a useful technique for rapid assessment of the composition of DTT microbiota and is particularly suitable for a first-pass comparison of multiple samples.^[@bibr61-1177932217733422]^ However, sequencing the 16S gene is currently the most common approach used in microbial classification.^[@bibr66-1177932217733422]^ The application of next-generation sequencing to microbial ecology has shown that the diversity in microbial populations is significantly higher than previously estimated by traditional culture-based and conventional molecular methods.^[@bibr67-1177932217733422]^ New technologies of DNA microarray (PhyloChip, Second Genome Inc, South San Francisco, USA) are now supporting microbiota investigations by 16S rDNA classification and offer the benefit of simultaneous detection of thousands of genes in a single shot.^[@bibr68-1177932217733422],[@bibr69-1177932217733422]^ Core genes enriched for housekeeping functions are also used to enrich classification based on 16S rDNA and to improve the resolution of microbial community structure.^[@bibr70-1177932217733422]^

Conclusions {#section12-1177932217733422}
===========

The qualitative and quantitative description of a microbiota, as adapted from Gumiel et al,^[@bibr8-1177932217733422]^ is more precise than a blind metagenomic analysis by DNA shotgun as long as complete genome sequences exist for the bacterial genera diagnosed by 16S rDNA. This is precisely the case in the present investigation as most of the genomes in the list of bacterial species identified by 16S rDNA sequencing by Gumiel et al^[@bibr8-1177932217733422]^ had companion species effectively sequenced that can be downloaded from the NCBI server. The most striking differences in overrepresented enzymatic functions that are found in GC-rich bacteria (prominent in the colonization of the triatomine digestive tract compared with GC-poor ones) are for the most part due to *oxidoreductases*. We conclude that this group of enzymatic functions allows GC-rich bacteria to outcompete GC-poor ones in an environment where the fermentation of a medium such as fresh blood may need some specific metabolic activities such as iron recycling and oxygen management. In such a context, GC-rich bacteria would have a comparative advantage in the colonization of their environment, thanks to their more complex enzymatic apparatus, however, at the cost of a larger genome that is slower to replicate. In consequence, invertebrate vectors are valuable systems in which to study the properties that may favor one particular microbial community as opposed to another.^[@bibr71-1177932217733422]^
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